Lanxess (LXS) Given a €53.00 Price Target at UBS Group

UBS Group set a €53.00 ($61.63) price target on Lanxess (ETR:LXS) in a report published on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Several other brokerages have also recently weighed in on LXS. Baader Bank set a €49.00 ($56.98) price target on shares of Lanxess and gave the stock a neutral rating in a research note on Friday, January 18th. JPMorgan Chase & Co. set a €60.00 ($69.77) price target on shares of Lanxess and gave the stock a buy rating in a research note on Tuesday. Goldman Sachs Group set a €58.00 ($67.44) price objective on Lanxess and gave the company a buy rating in a report on Monday, March 25th. Warburg Research set a €67.00 ($77.91) price objective on Lanxess and gave the company a buy rating in a report on Wednesday, April 10th. Finally, Morgan Stanley set a €54.00 ($62.79) price objective on Lanxess and gave the company a neutral rating in a report on Wednesday, April 10th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of €61.67 ($71.71).

Shares of LXS opened at €48.99 ($56.97) on Tuesday. The company has a market cap of $4.30 billion and a PE ratio of 10.40. Lanxess has a twelve month low of €39.47 ($45.90) and a twelve month high of €72.60 ($84.42). The company has a debt-to-equity ratio of 98.99, a current ratio of 2.57 and a quick ratio of 1.67.

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Read More: Understanding Options Trading

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.